Protocol summary

Study aim
determine The effects of food safety guidelines in comparison to the neutropenic diet on infection rates in patients with acute myeloid leukemia undergoing remission induction chemotherapy
Design
In this randomized clinical trial, Phase 2 will be taken from 68 patients using a general information questionnaire. Anthropometric measurements will be taken before the intervention begins. Three 24-hour food records will be taken from patients at the beginning, middle and end of the study, and their quality of life scores will be assessed using the EORTC QLQ-C30 questionnaire before the intervention and at the end of the intervention. To better follow the intervention, people will be consulted face to face twice a week
Settings and conduct
This study will be performed as a clinical trial on patients with acute myeloid leukemia under induction chemotherapy. Participants will be selected from patients admitted to Shariati Hospital in Tehran in 1400 based on the inclusion criteria.
Participants/Inclusion and exclusion criteria
Adults with AML undergoing induction chemotherapy, aged 20-55 years, will be enrolled in the absence of active infection at the time of admission and with a Karnofsky Performance Scale Index of more than 70%, and individuals with chronic obstructive pulmonary disease will fail. Chronic kidney, diabetes and asthma will not be included in the study.
Intervention groups
The neutropenic diet group uses neutropenic guidelines for 4 weeks. Participants in the Food Safety guidelines Group will receive detailed information, including how to buy, prepare, store, cook, and how to serve and consume food safely, for 4 weeks
Main outcome variables
Early onset of fever and neutropenia; Quality of Life ; Incidence of bacteremia; Incidence of pneumonia; Incidence of fungal infections; Duration of use of antibiotics or antifungals; Incidence of infectious diarrhea

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20220208053971N1
Registration date: 2022-04-16, 1401/01/27
Registration timing: registered_while_recruiting

Last update: 2022-04-16, 1401/01/27
Update count: 0
Registration date
2022-04-16, 1401/01/27
Registrant information
Name
Hamed Mohammadi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 8822 1444
Email address
hmohamadi@sina.tums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-04-02, 1401/01/13
Expected recruitment end date
2022-09-22, 1401/06/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effects of food safety guidelines in comparison to the neutropenic diet on infection rates in patients with acute myeloid leukemia undergoing remission induction chemotherapy: a randomized clinical trial
Public title
The effects of food safety guidelines in comparison to the neutropenic diet on infection rates in patients with acute myeloid leukemia
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
Diagnosis of acute myeloid leukemia Admission to the ward to start induction chemotherapy Willingness to cooperate
Exclusion criteria:
Infection or febrile illness at the time of admission Karnofsky Performance Status Scale less than 70% Chronic obstructive pulmonary disease, chronic renal failure, diabetes and asthma
Age
From 20 years old to 55 years old
Gender
Both
Phase
2
Groups that have been masked
No information
Sample size
Target sample size: 68
Randomization (investigator's opinion)
Randomized
Randomization description
Permuted Block Randomization method is used for randomization. In this method, eligible individuals with inclusion criteria are selected and then they are randomly selected using blocks with the size of 4 subjects, that blocks will be based on age (20 to 40 and 40 to 55 years) and gender (female / male). Then all possible sequences that can be written with block size of 4, were written on paper (for two groups with block size of 4, 6 sequences can be written). Then one of the numbers from 1 to 6 was considered for each sequence, for example for the ABBA sequence 1 and for the AABB sequence 2 and as such, one of the numbers 3 to 6 was considered for the other 4 sequences. Then, using random number table, the random numbers were selected from one point to the left or right. Wherever the random number was 1 to 6, the corresponding sequence was recorded on the paper, and wherever the numbers were 0 or 7, 8, 9, the next number that was between 1 to 6 was considered. This method continued until groups for the total number of participants were determined. Then, the names of subjects on the list were allocated to the specific groups according to the sequence of groups which had been determined by the above-mentioned procedure.
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Tehran University of Medical sciences
Street address
Room 605, Sixth Floor, Central Building of Tehran University of Medical Sciences, Qods Street, Keshavarz Blvd.
City
Tehran
Province
Tehran
Postal code
141556117
Approval date
2022-02-21, 1400/12/02
Ethics committee reference number
IR.TUMS.MEDICINE.REC.1400.1391

Health conditions studied

1

Description of health condition studied
Acute myeloid leukemia
ICD-10 code
C92.0
ICD-10 code description
Acute myeloblastic leukemia

Primary outcomes

1

Description
The first episode of fever
Timepoint
From the first day of intervention for 4 weeks
Method of measurement
Temperatures above 38.3 degrees at one time or above 38 at two times with an interval of one hour

2

Description
Incidence of bacteremia
Timepoint
From the first day of intervention for 4 weeks
Method of measurement
Patient file

3

Description
Incidence of pneumonia
Timepoint
From the first day of intervention for 4 weeks
Method of measurement
Patient file

4

Description
Incidence of fungal infections
Timepoint
From the first day of intervention for 4 weeks
Method of measurement
Patient file

5

Description
Duration of use of antibiotics or antifungals
Timepoint
From the first day of intervention for 4 weeks
Method of measurement
Patient file

6

Description
Infectious diarrhea
Timepoint
From the first day of intervention for 4 weeks
Method of measurement
Patient file

7

Description
Type of documented organisms
Timepoint
From the first day of intervention for 4 weeks
Method of measurement
Patient file

8

Description
Average length of hospital stay
Timepoint
From the first day of intervention for 4 weeks
Method of measurement
Patient file

9

Description
Quality of Life
Timepoint
Beginning and end of the study
Method of measurement
EORTC QLQ-C30 Questionnaire

10

Description
Number of infections per 1000 patient-day
Timepoint
From the first day of intervention for 4 weeks
Method of measurement
Patient file

11

Description
Nutritional status
Timepoint
Beginning and end of the study
Method of measurement
PG-SGA questionnaire

12

Description
Following the prescribed regimen
Timepoint
First, middle and end of the study
Method of measurement
Three 24-hour food records

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: The group of food safety guidelines will receive detailed information including how to buy, prepare, store, cook and how to serve and consume food safely and will follow this guidelines for 4 weeks. In order to assess the adherence of patients' diets during the intervention, three 24-hour 3-day food records will be taken from patients at the beginning, middle and end of the intervention. Quality of life scores will be assessed using the EORTC QLQ-C30 questionnaire before the intervention and at the end of the intervention. In order for people to better follow the intervention, face-to-face counseling will be done twice a week, and possible problems related to diet adherence will be examined and the necessary instructions will be provided.
Category
Prevention

2

Description
Intervention group: The neutropenic diet group uses standard neutropenic guidelines that generally include the elimination of raw fruits and vegetables, soft cheeses, probiotic yogurt, undercooked meat and eggs, and tap water, spices, and alcoholic beverages. They will follow this diet for 4 weeks. In order to assess the adherence of patients' diets during the intervention, three 24-hour 3-day food records will be taken from patients at the beginning, middle and end of the intervention. Quality of life scores will be assessed using the EORTC QLQ-C30 questionnaire before the intervention and at the end of the intervention. In order for people to better follow the intervention, face-to-face counseling will be done twice a week, and possible problems related to diet adherence will be examined and the necessary instructions will be provided.
Category
Prevention

Recruitment centers

1

Recruitment center
Name of recruitment center
Shariati hospital
Full name of responsible person
Dr. Hamed Mohammadi
Street address
Kargar Shomali Street, Jalal-e-Al-e-Ahmad hwy
City
Tehran
Province
Tehran
Postal code
1411713135
Phone
+98 21 8490 1000
Email
shariatihosp@tums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Dr. Akbar Fotoohi
Street address
Sixth Floor, Central Building of Tehran University of Medical Sciences, Qods Street, Keshavarz Blvd.
City
Tehran
Province
Tehran
Postal code
1417653761
Phone
+98 21 8163 3685
Email
msahrai@sina.tums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
No
Title of funding source
Tehran university of medical science
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Dr. Hamed Mohammadi
Position
Assistant professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
No. 44, Shahid Hojjat Doost Alley, Naderi St, Keshavarz Boulevard
City
Tehran
Province
Tehran
Postal code
1416643931
Phone
0098 21 889900285
Email
mohamadihd@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Dr, Hamed Mohammadi
Position
Assistant professor
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
No. 44, Shahid Hojjat Doost Alley, Naderi St, Keshavarz Boulevard
City
Tehran
Province
Tehran
Postal code
1416643931
Phone
0098 21 889900285
Email
mohamadihd@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Yasaman Hosseini
Position
student
Latest degree
Bachelor
Other areas of specialty/work
Nutrition
Street address
No. 69, 46 Alley, Qasr Dasht St
City
Shiraz
Province
Fars
Postal code
7193736378
Phone
+98 71 3626 4179
Email
h.yasaman97@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD
Due to confidentiality of participant information, it is not possible to publish it
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Not applicable
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Not applicable
Data Dictionary
Not applicable
Loading...